Vishal A. Patel, MD, FAAD, FACMS

Vishal A. Patel, MD, is an associate professor of dermatology at the George Washington University School of Medicine & Health Sciences and director of the Cutaneous Oncology Program at the George Washington Cancer Center.

Articles

Optimizing Multidisciplinary Collaboration in cSCC Care

November 11th 2025

Panelists discuss strategies for integrating dermatology, surgery, radiation, and oncology to deliver cohesive, patient-centered cSCC care.

Long-Term Follow-Up and Surveillance After Adjuvant Therapy

November 11th 2025

Panelists discuss strategies for long-term surveillance and management of patients with cSCC who have received adjuvant immunotherapy.

Clinical Trial Design and Outcomes in Adjuvant Immunotherapy for cSCC

November 11th 2025

Panelists discuss ongoing clinical trials evaluating adjuvant immunotherapy for cSCC and the implications of early outcomes for clinical practice.

Selecting Candidates for Adjuvant Immunotherapy in cSCC

November 11th 2025

Panelists discuss how clinicians identify which patients are most likely to benefit from adjuvant immunotherapy based on clinical and pathologic risk factors.

The Evolving Role of Adjuvant Immunotherapy

November 10th 2025

Panelists discuss ongoing clinical trials, including adjuvant immunotherapy studies, and identify which patients are most likely to benefit from these strategies.

Integrating Systemic Therapy Into cSCC Management

November 10th 2025

Panelists discuss the growing use of systemic immunotherapy for advanced or unresectable cSCC and how it integrates with other modalities.

Role of Radiotherapy in Managing cSCC

November 10th 2025

Panelists discuss when radiation therapy is appropriate for treating cSCC, and how it complements surgical management.

Identifying Surgical Candidates in cSCC

November 10th 2025

Panelists discuss how to identify appropriate surgical candidates and coordinate timely referral to specialized surgical teams.

Defining Primary Treatment Options in cSCC

November 10th 2025

Panelists discuss standard primary treatment modalities for cSCC, emphasizing surgical control and selective use of adjunctive therapy.

Recognizing High-Risk cSCC Patients for Early Biopsy

November 10th 2025

Panelists discuss patient populations requiring earlier biopsy and aggressive workup to detect high-risk cSCC.

Applying Guideline-Based Care Pathways in cSCC

November 10th 2025

Panelists discuss the importance of following evidence-based clinical pathways and national guidelines to streamline cSCC care.

Balancing In-Clinic Treatment and Referral in cSCC

November 10th 2025

Panelists discuss when cSCC can be managed within dermatology and when multidisciplinary referral is warranted.

Dermatology’s Role in Diagnosing and Managing cSCC

November 10th 2025

Panelists discuss how dermatologists serve as the first line of detection and play an essential role in early management and triage of cSCC.

Approach to Evaluating Suspected cSCC

November 10th 2025

Panelists discuss best practices for evaluating suspected cSCC, including lesion assessment, biopsy strategies, and initial patient workup.

Assessing Risk in cSCC: Key Clinical and Pathologic Markers

November 10th 2025

Panelists discuss clinical and pathological factors used to stratify cSCC into low-, high-, and very high-risk categories.

FDA Approval Insights: Adjuvant Cemiplimab for High-Risk CSCC: With Vishal A. Patel, MD, FAAD, FACMS

October 23rd 2025

Dr Patel discusses the clinical relevance of the FDA approval of adjuvant cemiplimab for the management of high-risk cutaneous squamous cell carcinoma.

Dr Patel on the FDA Approval of Adjuvant Cemiplimab for High-Risk Cutaneous Squamous Cell Carcinoma

October 16th 2025

Vishal A. Patel, MD, discusses the FDA approval of adjuvant cemiplimab for CSCC at high risk of recurrence following surgery and radiation.

Dr Patel on the Evolving Use of Neoadjuvant PD-1 Inhibitors in CSCC

April 22nd 2024

Vishal Patel, MD, FAAD, FACMS, discusses the evolving use of neoadjuvant and adjuvant PD-1 inhibition in cutaneous squamous cell carcinoma.

Practical Advice on the Evolving Management of CSCC

May 3rd 2023

Closing out their discussion on the management of cutaneous squamous cell carcinoma, expert panelists share clinical pearls and excitement for the future.

CSCC: Escalating Therapy for High-risk Patients

April 26th 2023

Dr Vishal Patel shares a surgeon’s perspective on MDC, followed by a discussion on how intensifying treatment after surgery may improve outcomes for higher-risk patients with CSCC.